NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

體外診斷 (IVD)的全球市場

Global InVitro Diagnostics Market - 2019-2026

出版商 DataM Intelligence 商品編碼 739311
出版日期 內容資訊 英文
商品交期: 約2個工作天內
價格
體外診斷 (IVD)的全球市場 Global InVitro Diagnostics Market - 2019-2026
出版日期: 2019年11月01日內容資訊: 英文
簡介

本報告提供全球體外診斷 (IVD) 市場相關調查分析,提供產業分析,市場分析,各地區分析,競爭情形,主要企業等相關的系統性資訊。

第1章 目錄

第2章 摘要整理

第3章 簡介

第4章 市場趨勢

  • 主要的發展

第5章 體外診斷 (IVD) 市場:產業分析

  • 推動市場要素
  • 阻礙市場要素
  • 威脅和機會
  • 波特的五力分析

第6章 體外診斷 (IVD) 市場:市場分析

  • 各技術
  • 各產品
  • 各應用
  • 各終端用戶

第7章 體外診斷 (IVD) 市場:各地區

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

第8章 體外診斷 (IVD) 市場:競爭情形

  • 市場佔有率分析
  • 主要策略
  • 產品基準

第9章 體外診斷 (IVD) 市場:競爭情形

  • BioMerieux
  • Danaher Corporation
  • Roche Diagnostics
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories
  • Bayer AG
  • Arkray, Inc.
  • Sysmex Corporation
  • Johnson & Johnson
  • Siemens AG

第10章 體外診斷 (IVD) 市場:附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

The Global In-Vitro Diagnostics Market was valued at USD xx million in 2018 and is estimated to reach USD xx million by 2025, with a CAGR of xx% during the forecast period (2019-2026).

Driving factors of the gloval In-Vitro Diagnostics Market:

The market is driven by several factors such as growing usage of POC diagnostics, increasing aging population and rapid occurrence of infectious diseases, but the market is also affected by the stringent regulations from the different regulatory bodies across the globe.

The growth of in-vitro diagnostics market is also hindered by the limited budget of hospitals and laboratories in the developing nations.

Some of the infectious disease, such as influenza testing, have well-established POCTs with approx.78% of flu testing performed at physician level in the US.

There is a huge competition in POC market segment which is leading to pricing pressure in the absence of meaningful developments in product differentiation.

Certain concerns over specificity and sensitivity of rapid tests are pushing towards the development of molecular assays, however these come at a significantly higher cost (>US$ 100 per patient, versus c. US$ 15 per patient for the rapid POCTs), which is likely to limit the volume growth of these tests outside of narrow patient populations (e.g. immuno-compromised) if consumable cost alone is accounted for.

Segmentation of global market:

The global In-Vitro Diagnostics market is segmented by a technique such as Immunochemistry Bacterial Toxicity Assays, POC diagnostics, Molecular Diagnostics, Hematology, Tissue Diagnostics, Microbiology, Self- blood glucose monitoring, and Others.

Based on Product type, the market is segmented into Instruments, Reagents, and Data Management Systems.

Further, the market is segmented by applications into Infectious Diseases, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Diseases, Nephrology, Drug Testing, HIV/AIDS, and Others. By end-user, the market is segmented into Laboratories, Hospitals, Academics, and Others.

Geographically, the market is segmented into North America, South America, Europe, Asia Pacific and RoW.

The report covers the factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles.

Competitive Insights:

The major companies in the In-Vitro Diagnostics market include BioMerieux, Danaher Corporation, Roche Diagnostics, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., Abbott Laboratories, Bayer AG, Arkray Inc., Sysmex Corporation, Johnson & Johnson, and Siemens AG.

Reasons to purchase this report:

Visualize the composition of the In-Vitro Diagnostics in the market across each indication, in terms of type and applications, highlighting the key commercial assets and players.

Identify commercial opportunities in In-Vitro Diagnostics by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of the In-Vitro Diagnostics market level 4/5 segmentation

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study

Product mapping in excel for the key In-Vitro Diagnostics products of all major market players

Table of Contents

1. Table of Contents

2. Executive Summary

3. Introduction

  • 3.1. Market Definition
  • 3.2. Research Methodology

4. Market Trends

  • 4.1. Key Developments

5. In-Vitro Diagnostics Market - Industry Analysis

  • 5.1. Market Drivers
  • 5.2. Market Restraints
  • 5.3. Threats and Opportunities
  • 5.4. Porter’s Five Forces

6. In-Vitro Diagnostics Market - Market Analysis

  • 6.1. In-Vitro Diagnostics Market - By Technique
    • 6.1.1. Immunochemistry Bacterial Toxicity Assays
    • 6.1.2. POC diagnostics
    • 6.1.3. Molecular diagnostics
    • 6.1.4. Hematology
    • 6.1.5. Tissue diagnostics
    • 6.1.6. Microbiology
    • 6.1.7. Self- blood glucose monitoring
    • 6.1.8. Others
  • 6.2. In-Vitro Diagnostics Market By Products
    • 6.2.1. Instruments
    • 6.2.2. Reagents
    • 6.2.3. Data Management Systems
  • 6.3. In-Vitro Diagnostics Market By Application
    • 6.3.1. Infectious Diseases
    • 6.3.2. Diabetes
    • 6.3.3. Cancer/Oncology
    • 6.3.4. Cardiology
    • 6.3.5. Autoimmune Diseases
    • 6.3.6. Nephrology
    • 6.3.7. Drug Testing
    • 6.3.8. HIV/AIDS
    • 6.3.9. Others
  • 6.4. In-Vitro Diagnostics Market By End User
    • 6.4.1. Laboratories
    • 6.4.2. Hospitals
    • 6.4.3. Academics
    • 6.4.4. Others

7. In-Vitro Diagnostics Market - Geographical Analysis

  • 7.1. North America
    • 7.1.1. The USA
    • 7.1.2. Canada
    • 7.1.3. Mexico
  • 7.2. Europe
    • 7.2.1. Germany
    • 7.2.2. France
    • 7.2.3. The UK
    • 7.2.4. Italy
    • 7.2.5. Spain
    • 7.2.6. Rest of Europe
  • 7.3. Asia Pacific
    • 7.3.1. China
    • 7.3.2. Japan
    • 7.3.3. India
    • 7.3.4. Australia
    • 7.3.5. Rest of Asia Pacific
  • 7.4. South America
    • 7.4.1. Brazil
    • 7.4.2. Argentina
    • 7.4.3. Rest of South America
  • 7.5 RoW

8. In-Vitro Diagnostics Market - Competitive Landscape

  • 8.1. Market Share Analysis
  • 8.2. Key Strategies
  • 8.3. Product Benchmarking

9. In-Vitro Diagnostics Market - Competitive Landscape

  • 9.1. BioMerieux
  • 9.2. Danaher Corporation
  • 9.3. Roche Diagnostics
  • 9.4. Becton, Dickinson and Company
  • 9.5. Bio-Rad Laboratories, Inc.
  • 9.6. Abbott Laboratories
  • 9.7. Bayer AG
  • 9.8. Arkray, Inc.
  • 9.9. Sysmex Corporation
  • 9.10. Johnson & Johnson
  • 9.11. Siemens AG

10. In-Vitro Diagnostics Market - Appendix

  • 10.1 Sources
  • 10.2 List of Tables
  • 10.3 Expert Panel Validation
  • 10.4 Disclaimer
  • 10.5 Contact Us